1Xiao-Fang Liu, Xian-Ting Zhou and Sheng-Quan Zou Department of Hepatobiliary Surgery, Affiliated Yantai Yuhuangding Hospital, Qingdao University Medical College, Yantai 264000, China and Department of General Surgery, Tongji Medical Hospital, Wuhan 430000, China.An analysis of 680 cases of cholangiocarcinoma from 8 hospitals[J].Hepatobiliary & Pancreatic Diseases International,2005,4(4):585-588. 被引量：12
2Huether A,Hopfner M,Baradari V,et al. Sor- afenib alone or as combination therapy for growth control of cholangiocarcinoma. Bio- chem Pharmaco! ,2007,73 : 1308-1317.
3Blechacz BRA, Smoot RL, Bronk SF, et al. Sorafenib inhibits signal transducer and activator of transcription - 3 signaling in cholangi cells by activating the phosphatase shatterproof 2. Hepatology 2009,50 : 1861-1870.
4Bengala C, Bertolini F, Malavasi N, et al. Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. Br J Cancer, 2009,102 : 68 -72.
5EI-Khoueiry AB, Rankin CJ, Ben-Josef E, et al. SWOG 0514 : a phase II study of sor- afenib in patients with unresectable or me- tastatic gallbladder carcinoma and cholan- giocarcinoma. Invest New Drugs, 2011, 30 : 1646-1651.
6Rosato RR, Almenara JA, Coe S, et al. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. Cancer Res, 2007, 67 : 9490-9500.
7Milella M, Falcone I, Conciatori F,et al. PTEN:multiple functions in human malignant tumors [ J ]. Front Onco1,2015,5 : 24.
8Mulholland D J, Kobayashi N, Ruscetti M, et al. Ptenloss and RAS/ MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells [ J ]. Cancer Res, 2012,72 (7) :1878-1889.
9Ibeawuchi C, Schmidt H, Voss R, et al. Exploring prostate cancer ge- nome reveals simultaneous losses of PTEN, FAS and PAPSS2 in pa- tients with PSA recurrence after radical prostatectomy [ J ]. Int J Mol Sci,2015,16(2) :3856-3869.
10Acloque H, Adams MS, Fishwick K, et al. Epithelial-mesenchymal transitions:the importance of changing cell state in development and disease [ J ]. J Clin Invest,2009,119 (6) : 1438-1449.
